Found: 3
Select item for more details and to access through your institution.
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 4, p. 519, doi. 10.1007/s00592-021-01830-7
- By:
- Publication type:
- Article
PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways.
- Published in:
- FASEB Journal, 2024, v. 38, n. 4, p. 1, doi. 10.1096/fj.202301748R
- By:
- Publication type:
- Article
Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09610-1
- By:
- Publication type:
- Article